Volume: 43 Issue: Supplementary 1
Year: 2023, Page: 189-195, Doi: https://doi.org/10.51248/.v43i1.2268
Introduction and Aim: In this study, a new sensitive and rapid HPLC method was developed to determine Metformin hydrochloride and Evogliptin tartrate in pharmaceutical dosage forms.
Materials and Methods: Chromatographic separation of Metformin and Evogliptin was achieved on Waters Alliance-e2695 by using Waters XTerra RP-18 150X4.6 mm, 3.5μ column, and the mobile phase containing Acetonitrile: KH2PO4: Methanol in the ratio of 50:40:10% v/v.
Results: The flow rate was 1.0 ml/min; detection was carried out by absorption at 228 nm using a photodiode array detector at ambient temperature.
Conclusion: This method was a simple, economical, suitable, precise, accurate and robust method for quantitative analysis of Metformin and Evogliptin study of its stability.
Keywords: RP-HPLC; Metformin; Evogliptin; Chromatographic conditions
1. World Health Organization. Diabetes. Available from: https://www.who.int/health-topics/diabetes. Last accessed on 08 October 2022.
2. Shende, M., Budde, B. R. Novel RP-HPLC method development and validation for simultaneous estimation of metformin, voglibose and pioglitazone in bulk and triple fixed drug combinations pharmaceutical dosage form. JDDT. 2019;9(1):30-37.
3. Rhee, S. J., Lee, S., Yoon, S. H., Cho, J. Y., Jang, I. J., Yu, K. S. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects. Drug Des Devel Ther. 2016;10:1411-1418.
4. Espinoza, Artavia. A. L., Fernandez, Vaglio. R. E. The new diagnosis and treatment of gestational diabetes mellitus. Rev Med Sinerg. 2019;4(4):41-54.
5. Agrawal, Y. P., Agrawal, M. Y., Jadhav, S. B., Shinde, R. J. Development and validation of novel uv spectrophotometric method for the determination of evogliptin tartrate in pharmaceutical dosage form. IJPER. 2020;54(4):1174-1179.
6. Cho, K. Bioanalytical validation for the determination of evogliptin and its metabolites m7/m8 in human plasma by liquid chromatography-tandem mass spectrometry. The 12th International Society for the Study of Xenobiotics (ISSX) meeting, United States of America. 2019;28-31.
7. Patel, A., Patel, R., Yadav, P. Development and validation of RP-HPLC method for estimation of evogliptin in pharmaceutical dosage form. IJPRA. 2021;6(2):775-781.
8. Tan, X., Hu, J. Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes. Expert Opin Pharmacother. 2016;17(9):1285-1293.
9. Esposito, K., Chiodini, P., Maiorino, M. I., Capuano, A., Cozzolino, D., Petrizzo, M., et al., A nomogram to estimate the HbA1c response to diff erent DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients. BMJ Open. 2015;5(2):e005892.
10. Yagi, S., Aihara, K., Akaike, M., Fukuda, D., Salim, H. M., Ishida, M., et al., Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2015;39(4):342-347.
11. Mamza, J., Mehta, R., Donnelly, R., Idris, I. Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database. Diabetes Technol Ther. 2016;18(2):85-92
12. Aiyalu, R., Ponnilavarasan, I., Rajan, N., Haribhuvanesh. Review of analytical method for quantitative estimation of metformin hydrochloride and evogliptin tartrate, a new dpp-4 inhibitor in pharmaceutical dosage form. 2021;22(4):173-191.
13. Sweetman, S., ed. Martindale: The Complete Drug Reference Vol. 1. (36th ed). London; Pharmaceutical Press. 2009:453-454.
Sai Sruthi Kaveripakam, Poojitha Sai Kuruva, Sreedevi Adikay. Development and validation of an RP-HPLC method for determination of Metformin and Evogliptin in bulk and pharmaceutical dosage forms. Biomedicine: 2023; 43(1) Supplementary issue: 189-195